Answer: KLOW may support gut barrier integrity, lower inflammatory signaling, and, downstream, may ease symptoms tied to chronic inflammation such as bloating, fatigue, brain fog, joint discomfort, and certain inflammatory skin patterns
Suzuki Y, Takadate T, Mizuma M, et al
The answer is yes but the more interesting comparison is at the higher end of the response distribution
Patients should not alter their dose without consulting their healthcare provider, as improper dosing can lead to adverse effects or reduced efficacy
G., & Coombes, J
in these cases, one can be switched to another, or they can both be given, if the glycemic target is not attained